News

Experts review how the SARS-Cov-2 virus can cause an immune overreaction in the form of potentially lethal cytokine storm.

The results from a new clinical trial exploring the use of a "live biotherapeutic" to treat recurring bacterial vaginosis are positive.

New research finds that adult skates can spontaneously repair injured cartilage. This is the first known example of adult cartilage repair in a research organism.

Researchers have found that vaccine design against SARS-CoV-2 can face specific challenges and that vaccine development approaches require an understanding of how the immune system naturally responds to a specific infection as well as how vaccines might trigger specific protective responses.

Four of six critically ill COVID-19 patients significantly improved after receiving an experimental therapeutic designed to reduce inflammation, a major cause of death from this disease, according to a new study.

Researchers have developed a novel system that enables the mass production of the major birch pollen allergen Bet v 1, used for allergy immunotherapy, in plant leaves in just a matter of days.

Scientists from the EPFL have developed a method to generate peptides that resist enzymatic degradation and can be taken orally.

Researchers have identified ST2 as a novel checkpoint molecule that could help T cells become more effective.

Vaccine development can often take many years. To accelerate the process, a team of scientists have come together to create a plan – a coordinated and efficient approach - to creating vaccines against COVID-19.

The use of focused ultrasound to defy the brain’s protective barrier could mean that doctors can deliver treatments directly into the brain to battle neurological diseases.